University of Parma — CureCurrent

How to interpret these research links

Connected source records

The exact organization name University of Parma appears in 28 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials28

Recruiting shown5

Roles2

SourceClinicalTrials.gov

Clinical trials

28 shown

Precision Nutrition to Improve Cardiometabolic Health With Dietary (Poly)PhenolsNCT06347094 · lead sponsor · 2024-04-22

Effect of BDP/Formoterol/G on Cough Efficacy in Moderate to Severe COPD Patients (EFFICACE)NCT05114434 · lead sponsor · 2021-11-01

PRogetto Salute ParmaNCT04282694 · lead sponsor · 2020-02-12

Safety and Efficacy of Early, seQUential Oral dIuretic Nephron blockAde In Acute Heart FailureNCT04062760 · lead sponsor · 2019-12-01

High Pasta vs. Low Pasta Diet in the Treatment of ObesityNCT03341650 · lead sponsor · 2015-11-02

Healthy Effects of an Innovative Probiotic PastaNCT02236533 · lead sponsor · 2014-03-01

The Links Between Water and Salt Intake, Body Weight, Hypertension and Kidney Stones: a Difficult PuzzleNCT01100580 · lead sponsor · 2010-05-01

Continuous Positive Airway Pressure (CPAP) Ventilation Using a Novel Full-Face Mask Versus Conventional HelmetNCT00944437 · lead sponsor · 2008-05-01

Search for Biomarkers in Human Glaucoma: Lymphocytes Alterations and Rate of ProgressionNCT00981422 · lead sponsor · 2007-06-01

Multifactorial Intervention in Type 2 Diabetes - ItalyNCT01240070 · lead sponsor · 2002-01-01

24-hour Control of Intraocular Pressure (IOP) in Ocular HypertensionNCT01655758 · lead sponsor · 2002-01-01

Brimonidine vs ALTP in Progressing Human GlaucomaNCT00466479 · lead sponsor · 1999-08-01

Biomarkers for Prognosis of Ambulatory Chronic Heart Failure PatientsNCT01113866 · lead sponsor · 1998-10-01

A Comparison Between Deep Sclerectomy and TrabeculectomyNCT00595855 · lead sponsor · 1997-10-01

Pigment Dispersion Syndrome: Natural History and Possible Protective Effect of a YAG Laser IridotomyNCT01053416 · lead sponsor · 1993-01-01

Polyphenol Metabotypes in People With Diabetes Type 2NCT06810635 · collaborator · 2026-03-04

Microbiota Mediated Flavonoid Metabolites for Cognitive HealthNCT07226674 · collaborator · 2025-11-25

Radiologic Features of Rheumatoid Arthritis Interstitial Lung Disease at Chest High Resolution Computed TomographyNCT07174102 · collaborator · 2025-01-08

Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes MellitusNCT05662189 · collaborator · 2022-03-15

Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of ImagingNCT05081115 · collaborator · 2021-04-01

Psychoeducational Intervention for Families With a Member Affected by Major DepressionNCT05988333 · collaborator · 2023-09-27

Echocardiographic Assessment and CLInical imPlication of Functional tricuSpid rEgurgitation in Heart Failure With Reduced or Preserved Ejection FractionNCT05209919 · collaborator · 2021-11-11

Mediterranean Enriched Diet for Tackling Youth ObesityNCT04719052 · collaborator · 2021-05-25

Empowering Consumers to 'PREVENT' Diet-related Diseases Through 'OMICS' SciencesNCT04590989 · collaborator · 2020-10-26

FOUND - Ancillary Study to Smile Protocol NCT03654105NCT04441814 · collaborator · 2019-07-23

MCID in 30 STS Test After PR in COPD PatientsNCT03627624 · collaborator · 2018-03-16

The Effect of Beclomethasone/Formoterol in Extra-fine Formulation on Quality of Life and SAD in COPD Patients.NCT04421742 · collaborator · 2017-05-31

Stress Echo 2020 - The International Stress Echo StudyNCT03049995 · collaborator · 2016-11-01

Drugs studied in this sponsor's trials

4 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing University of Parma as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.

bimatoprost1

brimonidine1

latanoprost1

travoprost1

bimatoprost RxCUI 283810 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial brimonidine RxCUI 134615 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial latanoprost RxCUI 43611 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial travoprost RxCUI 283809 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor15

collaborator13

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.